Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival

Oncogene

Volumn 25, Issue 28, 2006, Pages 3905-3913

  Sun, C ^a   Shi, Y ^a   Xu, L L ^a   Nageswararao, C ^a   Davis, L D ^a   Segawa, T ^a   Dobi, A ^a   McLeod, D G ^a,b   Srivastava, S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; Cell apoptosis; Cell proliferation; Mutation; p53; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; DOXORUBICIN; METRIBOLONE; MUTANT PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

ADENOVIRUS; ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN LNCAP; CELL SURVIVAL; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; SOMATIC MUTATION;

APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; GENES, P53; GENETIC VECTORS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANS-ACTIVATION (GENETICS);

EID: 33745589772     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209424     Document Type: Article

References (36)

1. Arrowsmith CH. (1999). Cell Death Differ 6: 1169-1173.
2. Bauer JJ, Sesterhenn IA, Mostofi KF, McLeod DG, Srivastava S, Moul JW. (1995). Clin Cancer Res 1: 1295-1300.
3. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R et al. (2004). Nat Med 10: 33-39.
4. Culig Z, Hobisch A, Bartsch G, Klocker H. (2000). Urol Res 28: 211-219.
5. Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A et al. (1999). Br J Cancer 81: 242-251.
6. Feldman BJ, Feldman D. (2001). Nat Rev Cancer 1: 34-45.
7. Gaddipati JP, Mcleod DG, Heidenberg HB, sesterhenn IA, Finger MJ, Moul JW et al. (1994). Cancer Res 54: 2861-2864.
8. Gelmann EP. (2002). J Clin Oncol 20: 3001-3015.
9. Grossmann ME, Huang H, Tindall DJ. (2001). J Natl Cancer Inst 93: 1687-1697.
10. Haag P, Bektic J, Bartsch G, Klocker H, Eder IE. (2005). J Steroid Biochem Mol Biol 96: 251-258.
11. Han G, Buchanan G, Ittmann M, Harris JM, Yu X, Demayo FJ et al. (2005). Proc Natl Acad Sci USA 102: 1151-1156.
12. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. (1998). Proc Natl Acad Sci USA 95: 2509-2514.
13. Heidenberg HB, Sesterhenn IA, Gaddipati JP, Weghorst CM, Buzard GS, Moul JW et al. (1995). J Urol 154: 414-421.
14. Huggins C, Hodges CV. (1941). Cancer Res 1: 293-297.
15. Ioffe ML, White E, Nelson DA, Dvorzhinski D, DiPaola RS. (2004). Prostate 61: 243-247.
16. Landis SH, Murray T, Bolden S, Wingo PA. (1999). CA Cancer J Clin 49: 8-31.
17. Liao X, Tang S, Thrasher JB, Griebling TL, Li B. (2005). Mol Cancer Ther 4: 505-515.
18. Nakao R, Haji M, Yanase T, Ogo A, Takayanagi R, Katsube T et al. (1992). J Clin Endocrinol Metab 74: 1152-1157.
19. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. (1995). Cancer Res 55: 4438-4445.
20. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE et al. (2005). Oncogene 24: 6773-6784.
21. Schuurmans AL, Bolt J, Veldscholte J, Mulder E. (1990). J Steroid Biochem Mol Biol 37: 849-853.
22. Segawa T, Takebayashi H, Kakehi Y, Yoshida O, Narumiya S, Kakizuka A. (1998). Cancer Res 58: 2282-2287.
23. Shi XB, Ma AH, Xia L, Kung HJ, de Vere White RW. (2002). Cancer Res 62: 1496-1502.
24. Small EJ. (1998). Curr Opin Oncol 10: 244-252.
25. Sobel RE, Sadar MD. (2005). J Urol 173: 342-359.
26. Srivastava S, Katayose D, Tong YA, Craig CR, McLeod DG, Moul JW et al. (1995). Urology 46: 843-848.
27. Taplin ME, Balk SP. (2004). J Cell Biochem 91: 483-490.
28. Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B et al. (1999). Cancer Res 59: 2511-2515.
29. Tsui KH, Chang PL, Lin HT, Juang HH. (2004). J Urol 172: 2035-2039.
30. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL et al. (2003). Prostate 57: 205-225.
31. Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E et al. (1990). Biochem Biophys Res Commun 173: 534-540.
32. Wen AJ, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH et al. (2000). Cancer Res 60: 6841-6845.
33. Xu LL, Srikantan V, Sesterhenn IA, Augustus M, Dean R, Moul JW et al. (2000). J Urol 163: 972-979.
34. Yang C, Cirielli C, Capogrossi MC, Passaniti A. (1995). Cancer Res 55: 4210-4213.
35. Yap DB, Hsieh JK, Chan FS, Lu X. (1999). Oncogene 18: 7681-7689.
36. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. (2002). Cancer Res 62: 1008-1013.